MERCK KGAA/ DE0006599905 /
2024-04-26 11:17:42 AM | Chg. +0.9000 | Volume | Bid4:31:10 PM | Ask4:31:10 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
151.3000EUR | +0.60% | 120 Turnover: 18,149 |
152.1000Bid Size: 300 | 152.2500Ask Size: 300 | 19.58 bill.EUR | 1.45% | 23.34 |
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA